← SynDRA
(R,S)-INDATRALINE
SynDRA canonical compound SYN0004943 — structure-anchored drug synonym record
| Primary target(s) | MAOB |
|---|
| Mechanism of action | Norepinephrine transporter inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Norepinephrine transporter inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15B
- MAPT
- TP53
- THPO
- TDP1
- SLC6A4
- SLC6A3
- SLC6A2
- RGS4
- RAB9A
- PMP22
- NPC1
- NFKB1
- MTOR
- LMNA
- ARSA
- KMT2A
- HSPA5
- GMNN
- EHMT2
- DRD1
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- ATXN2
- ATAD5
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- CP3A4
- DLD
- IF4G1
- KCMA1
- KCMB1
- KCMB2
- KCNH2
- M4K2
- MDM2
- MDM4
- NPBW1
- OXYR
- SC6A3
- UBE2N
Cross-references
Synonyms
- indatraline
- Indatraline
- Indatralinum
- 4U40Y96J1Z
- (+-)-trans-3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine
- indatralina
- RefChem:148107
- DTXCID2023981
- Indatraline [INN]
- (+/-)-trans-3-(3,4-dichlorophenyl)-N-methyl-1-indanamine
- UNII-4U40Y96J1Z
- Lu 19-005
- Lopac-I-119
- Lopac0_000684
- orb1740992
- SCHEMBL9252640
- SCHEMBL31307192
- CHEBI:94467
- BDBM50095618
- PDSP1_001502
- PDSP2_001486
- CCG-204769
- SDCCGSBI-0050662.P002
- NCGC00015532-01
- NCGC00025223-02
- NCGC00025223-03
- NCGC00025223-04
- NCGC00025223-08
- NCGC00025223-09
- NS00125447
- T68488
- 3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine hcl
- BRD-K01649396-003-07-1
- Indatraline (hydrochloride)
- (1r,3s)-indatraline hydrochloride
- Tox21_111238
- CAS-96850-13-4
- LP00684
- SR-01000075409-1
Look up (R,S)-INDATRALINE in the interactive SynDRA portal →